Innergex strategically reduced its dividend and up-financed hydro assets. Read more to see why INGXF stock has substantial ...

YieldMax TSLA Option Income Strategy ETF has historically underperformed, but recent political developments involving Elon ...

I reiterate a 'Buy' rating for Zoetis with a one-year target price of $210 per share, driven by strong product performance ...

Palantir’s multi-decade prowess in advanced mission-critical analytics is already making its AI genuinely valuable. Read why ...

Booz Allen Hamilton anticipates significant growth in its cybersecurity business. Read why I reiterate a Strong Buy rating ...

Chances are high that the Bitcoin dominance has either already peaked for this cycle or will peak in November or December ...

Microsoft's $13 billion partnership with OpenAI underscores its ambitious AI strategy. Click here to read why MSFT stock is a ...

The acquisition reshapes FREYR Battery into a profitable growth company while providing immediate revenue streams. See why ...

Meta Platforms delivered strong Q3 results, but it's not the right time to initiate a position in the company. See why META ...

Microsoft's Intelligent Cloud segment sees growth from Azure AI adoption. Read why I remain bullish on MSFT stock and ...

David Abrams’ 13F portfolio value increased from $5.11B to $6.23B in Q3 2024, with the top three stakes comprising ~66%. The ...

Global Medical REIT's Q3-2024 results show flat rental revenue and AFFO. Check out a few concerns with GMRE stock and why it ...